These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11474227)
1. Combined treatment with low-dose pravastatin and fish oil in post-renal transplantation dislipidemia. Grekas D; Kassimatis E; Makedou A; Bacharaki D; Bamichas G; Tourkantonis A Nephron; 2001 Aug; 88(4):329-33. PubMed ID: 11474227 [TBL] [Abstract][Full Text] [Related]
2. Impact of fluvastatin on hyperlipidemia after renal transplantation. Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients. Penson MG; Fricker FJ; Thompson JR; Harker K; Williams BJ; Kahler DA; Schowengerdt KO J Heart Lung Transplant; 2001 Jun; 20(6):611-8. PubMed ID: 11404165 [TBL] [Abstract][Full Text] [Related]
4. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation. Butani L Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046 [TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation. Demetriou D; Shabpar A; Böhmig G; Schmaldienst S; Hörl WH; Watschinger B Wien Klin Wochenschr; 2000 Apr; 112(8):358-61. PubMed ID: 10849941 [TBL] [Abstract][Full Text] [Related]
6. Therapy of post-renal transplantation hyperlipidaemia: comparative study with simvastatin and fish oil. Castro R; Queirós J; Fonseca I; Pimentel JP; Henriques AC; Sarmento AM; Guimarães S; Pereira MC Nephrol Dial Transplant; 1997 Oct; 12(10):2140-3. PubMed ID: 9351079 [TBL] [Abstract][Full Text] [Related]
7. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW; Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001 [TBL] [Abstract][Full Text] [Related]
8. Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Contacos C; Barter PJ; Sullivan DR Arterioscler Thromb; 1993 Dec; 13(12):1755-62. PubMed ID: 8241095 [TBL] [Abstract][Full Text] [Related]
10. Effect of a HMG-CoA reductase inhibitor combined with hormone replacement therapy on lipid metabolism in Japanese women with hypoestrogenic lipidemia: a multicenter double-blind controlled prospective study. Ohta H; Komukai S; Sugimoto I; Fuyuki T; Makita K; Takamatsu K; Horiguchi F; Nozawa S Maturitas; 1998 Jun; 29(2):163-71. PubMed ID: 9651906 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A. Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976 [TBL] [Abstract][Full Text] [Related]
12. The effects of pravastatin on hyperlipidemia in renal transplant recipients. Yoshimura N; Oka T; Okamoto M; Ohmori Y Transplantation; 1992 Jan; 53(1):94-9. PubMed ID: 1733092 [TBL] [Abstract][Full Text] [Related]
13. Statins improve visual field alterations related to hypercholesterolemia. Alcalá A; Jansen S; Téllez T; Gómez-Huelgas R; Pérez O; Egido J; Farkouh ME Atherosclerosis; 2010 Apr; 209(2):510-4. PubMed ID: 19892351 [TBL] [Abstract][Full Text] [Related]
14. Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial. Zachoval R; Gerbes AL; Schwandt P; Parhofer KG J Hepatol; 2001 Jul; 35(1):86-91. PubMed ID: 11495047 [TBL] [Abstract][Full Text] [Related]
15. Dyslipidemia in patients with chronic renal failure and in renal transplant patients. Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552 [TBL] [Abstract][Full Text] [Related]
16. Pravastatin reduces serum cholesterol and low density lipoprotein concentrations following pancreas transplantation. al'Halawani MH; Larsen JL; Miller S; Frisbie K; Taylor RJ; Stratta RJ Transplantation; 1994 Dec; 58(11):1204-9. PubMed ID: 7992364 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of acipimox and pravastatin in patients with combined hyperlipidemia. Fogari R; Marasi G; Vanasia A; Zoppi A; Lusardi P; Preti P Int J Clin Pharmacol Ther; 1997 Feb; 35(2):61-4. PubMed ID: 9147709 [TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol. Tani S; Nagao K; Hirayama A Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320 [TBL] [Abstract][Full Text] [Related]